Essex Investment Management’s Mondelez International MDLZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-27
Closed -$1.99K 314
2024
Q3
$1.99K Hold
27
﹤0.01% 299
2024
Q2
$1.77K Hold
27
﹤0.01% 301
2024
Q1
$1.89K Hold
27
﹤0.01% 302
2023
Q4
$1.96K Hold
27
﹤0.01% 312
2023
Q3
$1.87K Hold
27
﹤0.01% 354
2023
Q2
$1.97K Hold
27
﹤0.01% 368
2023
Q1
$1.88K Sell
27
-100
-79% -$6.62K ﹤0.01% 383
2022
Q4
$8K Hold
127
﹤0.01% 375
2022
Q3
$7K Hold
127
﹤0.01% 382
2022
Q2
$8K Hold
127
﹤0.01% 395
2022
Q1
$8K Hold
127
﹤0.01% 376
2021
Q4
$8K Hold
127
﹤0.01% 388
2021
Q3
$7K Hold
127
﹤0.01% 403
2021
Q2
$8K Hold
127
﹤0.01% 401
2021
Q1
$7K Hold
127
﹤0.01% 430
2020
Q4
$7K Hold
127
﹤0.01% 448
2020
Q3
$7K Hold
127
﹤0.01% 448
2020
Q2
$6K Hold
127
﹤0.01% 404
2020
Q1
$6K Hold
127
﹤0.01% 373
2019
Q4
$7K Hold
127
﹤0.01% 453
2019
Q3
$7K Hold
127
﹤0.01% 446
2019
Q2
$7K Hold
127
﹤0.01% 455
2019
Q1
$6K Hold
127
﹤0.01% 459
2018
Q4
$5K Buy
+127
New +$5.41K ﹤0.01% 455

Other funds holding MDLZ

Essex Investment Management's MDLZ Position: Q4 2024 in Review

Essex Investment Management sold out of Mondelez International (MDLZ) in Q4 2024, closing a stake of 27 shares — an estimated $1.99K sold.

Essex Investment Management first reported a position in MDLZ in Q4 2018 and held it in 24 quarters. The position peaked at $8K in Q4 2022. 1,994 funds tracked by Wall St. Rank hold MDLZ as of Q4 2024.

  • Essex Investment Management reported no remaining Mondelez International position as of Q4 2024 after selling out during the quarter.
  • Essex Investment Management sold 27 Mondelez International shares in Q4 2024, an estimated $1.99K.
  • Essex Investment Management first reported a position in Mondelez International in Q4 2018 and held it in 24 quarters.
  • Essex Investment Management's Mondelez International position peaked at $8K in Q4 2022.
  • 1,994 funds tracked by Wall St. Rank held Mondelez International as of Q4 2024.

Based on Essex Investment Management's 13F filing for Q4 2024, filed 7 Feb 2025.